Ever wondered what happens to starved cells that don't die? Do they do anything? Check @franzi_la last paper. --Spoiler: they tell other cells that they're hungry (1/15) #Tweetorial 👇 https://t.co/2pg0kjw66s @idibell_cat @ICOnoticies @CampusBellvitge

'Alternative' translational control by mTOR through the RNA binding protein DDX21, from Monika Wolkers' team mTOR signaling during T cell activation promotes cytokine production in T cells through 3′ UTR-mediated translation control: Molecular Cell.

Metabolic environment-driven remodeling of mitochondrial ribosomes regulates translation and biogenesis https://t.co/IiPk4jcp0J

Good morning! (In Europe) Here's a selection of papers on cancer metabolism, cancer-inmunometabolism and cancer and diet and systemic metabolism (cachexia), as well as nutrient sensing and hypoxia. MetaboList, November 2025 https://t.co/E4s3zRkqWH

Glucose and ribose in an asteroid! Bio-essential sugars in samples from asteroid Bennu - Furukawa et al | Nature Geoscience

Des de l'@ICO_oncologia i @hbellvitge hem participat al reportatge “Càncer, investigar dóna vida” de @som3cat i #30minuts, un repàs intens i esperançador de com han evolucionat els tractaments i la supervivència del #càncer en les darreres 3 dècades 👇 https://t.co/iJI9UtLQhp

Nice comment by Angela Montero and Lydia Finley @lydfinley https://t.co/qGtsnfx0BE

That’s cool @RutterLab

Excited to share our new preprint—the main project of my postdoc in the Kaelin lab! Blocking HIF2 doesn’t just slow tumors—it can reverse cachexia and hypercalcemia in kidney cancer. In the OSRC-2 model, HIF2 inhibition restored weight, preserved fat/muscle, and rescued survival.

Targeting of HIF2-driven cachexia in kidney cancer @NatureMedicine @RemailehAbu @kaelin_lab @DanaFarber @harvardmed https://t.co/HuXjqnUvdl

This has to stop

Ferroptosis induced by inhibition of GPX4 suppressed tumor growth in 2D, but not in 3D or in vivo. Lipids are different "Lipid Composition Alters Ferroptosis Sensitivity"

Rejuvenating the blood: a new pharmacological intervention targeting RhoA in hematopoietic stem cells🩸 According to a study published in @NatureAging, treating these cells with the drug Rhosin rejuvenates them and helps produce healthier blood cells💪 👉 https://t.co/QOfnkoLblK

Unintended consequence of posting preprints: spammer journal emails asking to publish *it*. 20 daily scientific spam emails instead of 10

Know this”, he says. “The main function of reviewers and the editorial process is to take your lovely, wonderful paper That you love so much, that you adore And convert it, step by step, into that which you will call ‘That frogging’ paper Mole @J_Cell_Sci https://t.co/OLAelKMkFV

Join us in San Francisco for an evidence based, clinically focused dinner session on cancer cachexia at #ASCOGI. Secure your spot for this workshop that brings together leaders in GI oncology and metabolism:

RESEARCH | @xiaobowang, I Tabas et al (Columbia U, USA) #Hepatocyte Caspase-8 in #MASH promotes the activation of hepatic stellate cells and liver fibrosis through an #apoptosis-independent mechanism 🐭 https://t.co/4FFbR1ThpX

More interesting research from our Institute. Oncology Bellvitge rocks

Interested in doing clinical science in the best city in the world? Clinician-Investigator job with NYU Grossman School of Medicine

I strongly recommend this group, who are our neighbors. You would learn a lot, publish well and have fun. We are also looking for an applicant, by the way :-)

Another favorite from last month, also from a European group: "Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferation" https://t.co/bLiuagMUhj @VagnerCurie